NCT00112567View on ClinicalTrials.gov

Total-Body Irradiation, Thiotepa, and Fludarabine in Treating Young Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2003

Study Completion Date

July 31, 2007

Conditions

LeukemiaMyelodysplastic Syndromes

Interventions

DRUG

fludarabine phosphate

DRUG

thiotepa

PROCEDURE

peripheral blood stem cell transplantation

RADIATION

radiation therapy

Trial Locations (2)

98104

Fred Hutchinson Cancer Research Center, Seattle

98109-1023

Seattle Cancer Care Alliance, Seattle

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Fred Hutchinson Cancer Center

OTHER

NCT00112567 - Total-Body Irradiation, Thiotepa, and Fludarabine in Treating Young Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer | Biotech Hunter | Biotech Hunter